Article Details
Retrieved on: 2021-06-06 03:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley reduced their target price on Legend Biotech from $55.00 to $50.00 and set an "overweight" rating on the stock in a research report on ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here